InsiderClue
Insiders · Profile

Hoerter Steven L.

Director at MBX Biosciences · Chief Commercial Officer at AGIOS PHARMACEUTICALS. Filing since 23 Jan 2018. CIK 0001533451

MBX MBX Biosciences, Inc. Director · 1 trade AGIO AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
MBX MBX Biosciences, Inc.
17 Oct 2025
Director
Bought
20,000
$264.98K
opened
AGIO AGIOS PHARMACEUTICALS, INC.
4 Mar 2019
Chief Commercial Officer
Sold, plan not stated
5,000
$340.00K
31.4%
AGIO AGIOS PHARMACEUTICALS, INC.
1 Mar 2019
Chief Commercial Officer
Sold, plan not stated
5,000
$330.05K
31.4%
AGIO AGIOS PHARMACEUTICALS, INC.
24 Aug 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$153.59K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
25 Jul 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$173.39K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
22 Jun 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$200.04K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
23 May 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$175.81K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
23 Apr 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$176.20K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
22 Mar 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$173.53K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
22 Feb 2018
Chief Commercial Officer
Sold, plan not stated
2,050
$161.19K
100%
AGIO AGIOS PHARMACEUTICALS, INC.
23 Jan 2018
Chief Commercial Officer
Sold, plan not stated
25,000
$1.87M
100%
11 decisions on file.